Stability of CSF β-Amyloid1–42 and Tau Levels by APOE Genotype in Alzheimer Patients

Publisher： Karger

E-ISSN： 1421-9824|22|1|48-53

ISSN： 1420-8008

Source： Dementia and Geriatric Cognitive Disorders, Vol.22, Iss.1, 2006-06, pp. : 48-53

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CSF Biomarkers for Alzheimer’s Disease: Levels of β-Amyloid, Tau, Phosphorylated Tau Relate to Clinical Symptoms and Survival

By  

Dementia and Geriatric Cognitive Disorders, Vol. 21, Iss. 3, 2006-02 ,pp. : 131-138

Karger

Access to resources Recommend Favorite

Cerebrospinal Fluid Phospho-Tau, Total Tau and β-Amyloid1–42 in the Differentiation between Alzheimer’s Disease and Vascular Dementia

By  

Dementia and Geriatric Cognitive Disorders, Vol. 14, Iss. 4, 2002-11 ,pp. : 183-190

Karger

Access to resources Recommend Favorite

Concentrations of Metals, β-Amyloid and Tau-Markers in Cerebrospinal Fluid in Patients with Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 28, Iss. 1, 2009-08 ,pp. : 88-94

Karger

Access to resources Recommend Favorite

β-Amyloid (1–42) Levels in Cerebrospinal Fluid and Cerebral Atrophy in Mild Cognitive Impairment and Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders Extra, Vol. 1, Iss. 1, 2011-11 ,pp. : 393-401

Karger

Access to resources Recommend Favorite

Unaltered Plasma Levels of β-Amyloid(1–40) and β-Amyloid(1–42) upon Stimulation of Human Platelets

By  

Dementia and Geriatric Cognitive Disorders, Vol. 16, Iss. 2, 2003-06 ,pp. : 93-97

Karger

Access to resources Recommend Favorite